Analgesics in the US has delivered a subdued performance in 2026, expected to register retail value sales of USD6,666 million and a negligible increase in current value terms, signalling a shift away from reliance on demographic and economic growth for expansion. The environment is becoming less attractive for traditional drug-based offerings, with growth largely confined to formats and brands that address prevention, holistic wellness, and convenience in a context of low population growth and fewer acute illness events. Nevertheless, dynamic gains are being realised by topical analgesics/anaesthetic, which is set to expand while systemic analgesics contracts, underscoring the need for differentiation and innovation. To succeed, brands must adopt integrated portfolios that bridge acute and preventative solutions, invest in digital engagement and omnichannel distribution, and prioritise product and messaging strategies that resonate with evolving consumer preferences for non-drug, technology-enabled, and wellness-oriented pain management.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in USA with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in USA, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in USA report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in USA?
- Which are the leading brands in Analgesics in USA?
- How are products distributed in Analgesics in USA?
- How has the regulatory and operating environment for Analgesics changed in USA?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Key Data Insights
Key Industry Trends
Topical analgesics/anaesthetic sees dynamic growth, due to perceived safety and targeted relief
Walgreen’s closures accelerate shift to mass and online retail
Non-drug pain solutions disrupt loyalty to OTC analgesics
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
Demand for localised solutions set to drive continued growth for topical analgesics/anaesthetic
Holistic pain management will be necessary, not just a focus on OTC analgesics
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
McNeil and Haleon leverage portfolio breadth to extend leadership
Kenvue acquisition by Kimberly-Clark set to reinforce position of McNeil
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Amazon and Walmart drive consumers to digital-first pain relief
Rise of retail e-commerce set to continue as offline access becomes more limited
Chart 1 Retail Channels 2021-2026
Digital discovery and bundle design lead the innovation agenda
Channel-led innovation reaches consumers
Competitive encroachment redefines where value accrues
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031
Country Reports Disclaimer
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!